In fact, it has a specific purpose preparing the body for the higher therapeutic doses that follow
The human body, unable to process glucose, would succumb to the slow, destructive creep of high blood sugar
50, 876881.10.1053/meta.2001.24915 122 GonzlezC
If tiredness is severe, worsening or lasting beyond the adjustment period, a healthcare provider can help determine whether semaglutide is the cause or if something else may be contributing
These peptides, which include glucose-dependent insulinotropic peptide (GIP) and GLP1, are responsible for the incretin effect, which explains why the stimulus for insulin release is stronger upon receiving an oral glucose load, rather than an intravenous one.40,41 Dipeptidyl peptidase 4 (DPP-4) is the protein that cleaves and inactivates GLP-1 and GIP in a few minutes,40 thus the medications that inhibit said aminopeptidase increase the circulating levels of the incretins, enabling the stimulation of glucose-dependent insulin secretion in the pancreatic islets, through membrane receptors in the cells, to persist.41 Sitagliptin, linagliptin, saxagliptin, vildagliptin, and alogliptin, among others, belong to the group of DPP-4 inhibitors (iDDP-4)
